the Effects and Safety of Idarubicin-strengthened Pretreatment Program and Conventional Busulfan Cyclophosphamide Pretreatment Program on High-risk Acute Myeloid Leukemia Patient

Clinical trial NCT01766375 · UNKNOWN

Trial details

NCT number: NCT01766375
Sponsor: Guangxi Medical University
Status: UNKNOWN
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2012-08-01
Primary completion: 2016-01-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.